Drug Shortage Report for AMERGE

Last updated on 2021-04-17 History
Report ID 136050
Drug Identification Number 02237820
Brand name AMERGE
Common or Proper name naratriptan hydrochloride tablets
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) NARATRIPTAN
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 2's
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-04-08
Estimated end date 2021-04-26
Actual end date 2021-04-16
Shortage status Resolved
Updated date 2021-04-17
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2021-04-17 English Compare
v10 2021-04-16 French Compare
v9 2021-04-16 English Compare
v8 2021-04-09 English Compare
v7 2021-04-08 French Compare
v6 2021-04-08 English Compare
v5 2021-04-01 French Compare
v4 2021-04-01 English Compare
v3 2021-04-01 English Compare
v2 2021-03-19 French Compare
v1 2021-03-19 English Compare